Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
35.44
-1.02 (-2.80%)
At close: Oct 17, 2025, 4:00 PM EDT
35.80
+0.36 (1.02%)
After-hours: Oct 17, 2025, 4:10 PM EDT
AAPG Employees
Ascentage Pharma Group International had 567 employees as of December 31, 2024. The number of employees decreased by 16 or -2.74% compared to the previous year.
Employees
567
Change (1Y)
-16
Growth (1Y)
-2.74%
Revenue / Employee
$96,163
Profits / Employee
-$285,386
Market Cap
3.23B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 567 | -16 | -2.74% |
| Dec 31, 2023 | 583 | 3 | 0.52% |
| Dec 31, 2022 | 580 | -33 | -5.38% |
| Dec 31, 2021 | 613 | 180 | 41.57% |
| Dec 31, 2020 | 433 | 23 | 5.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AAPG News
- 6 weeks ago - Ascentage Pharma Group International (AAPG) Presents At Citi's Biopharma Back To School Conference Transcript - Seeking Alpha
- 2 months ago - Ascentage Pharma Reports 2025 Interim Unaudited Six Months Financial Results and Business Updates - GlobeNewsWire
- 2 months ago - Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and EMA - GlobeNewsWire
- 2 months ago - Ascentage Pharma to Report 2025 Six Month Interim Results and Provide Corporate Update on August 20, 2025 - GlobeNewsWire
- 2 months ago - Ascentage Pharma to Participate in Evercore China Biotech Summit - GlobeNewsWire
- 3 months ago - Ascentage Pharma Announces Closing of Placement Shares in Top-Up Placement - GlobeNewsWire
- 3 months ago - Ascentage Pharma Announces Pricing of Top-Up Placement - GlobeNewsWire
- 3 months ago - Ascentage Pharma Announces Proposed Top-Up Placement - GlobeNewsWire